Viewing nowPhentacin Tablets (Phenmetrazine Tartrate)
Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.

MFDS item code 200512155 · Approved 2005.11.22
Weight loss adjunct therapy for patients with obesity (including body mass index and risk factors)
This medication is used for obese patients who have difficulty losing weight through diet or exercise. It is especially effective in patients with a BMI of 30 or more, or in patients with a BMI of 27 or more who have risk factors such as hypertension, diabetes, or hyperlipidemia. This drug is used as a short-term adjunct to weight-loss therapy based on calorie restriction and should be used alone without taking other appetite suppressants.
As Phenmetrazine Tartrate, 35 mg is administered orally 2 to 3 times a day 1 hour before meals. The dosage should use the minimum effective dose but may be adjusted individually for proper responses. For some patients, 17.5 mg once a day may be adequate. The dosage should not exceed 70 mg per dose or more than 3 times a day. This drug is to be administered for a short period (within 4 weeks). Weight loss
This drug should only be used alone as serious heart conditions may occur if used with other appetite suppressants. This drug should only be used for a short duration when treating exogenous obesity and taking other weight-loss medications is unsafe. Prolonged use of this drug can significantly increase the risk of serious pulmonary vascular disease known as pulmonary hypertension. If symptoms such as shortness of breath, chest pain, fainting, or leg swelling occur during exercise, stop taking the medication immediately and seek medical evaluation. A cardiac evaluation is needed before administration due to risks associated with heart valve diseases; individuals with heart murmurs or valve diseases should avoid this drug. This drug is contraindicated in people with certain heart diseases, hypertension, hyperthyroidism, glaucoma, anxiety disorders, and a history of drug abuse. Also, this drug should not be taken by children under 16 years or by pregnant women or women who may become pregnant. Patients with mild hypertension, nursing women, and diabetic patients should exercise special caution when using this drug, and diabetic patients may need adjustments to their insulin dosage. This drug may cause increased or irregular heartbeats, anxiety, insomnia, dizziness, headaches, gastrointestinal disturbances, changes in sexual function, rapid urination, urinary retention, and erectile dysfunction. If tolerance develops, do not increase the dose but discontinue use, and caution is needed when driving or operating machinery. In cases of overdose, severe anxiety, coma, seizures, blood pressure changes, and vomiting may occur, requiring immediate treatment. This drug should be stored in a safe place out of reach of children, as it is classified as a controlled substance with potential for abuse. Sudden cessation after prolonged high-dose use may cause extreme fatigue and depression, hence the dosage should be tapered off under medical direction.
Rash, peripheral edema (possible pulmonary hypertension), exercise-related shortness of breath, symptoms of angina, fainting (possible pulmonary hypertension)
Palpitations, tachycardia, increased blood pressure, overexcitement, anxiety, dizziness, insomnia, tremors, euphoria, headache, psychiatric disorders occurring infrequently at recommended doses, agitation, flushing, sweating, blurred vision, dry mouth, discomfort, diarrhea, constipation, nausea, abdominal pain, changes in sexual drive, increased urination, urinary retention, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This drug may be sensitive to air or moisture, so it should be stored in a tightly closed container. It is advisable to keep the storage temperature between 1°C and 30°C at room temperature. This will help maintain the drug's effectiveness for a long period.
White round tablet
For domestic use - 30 tablets/bottle, For domestic use - 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPhendimetrazine Tartrate 35mg
Tablet · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Albuzene Korea Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Joah Pharmaceutical Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Bionex Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
PharmGen Science Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Dae Won Pharmaceutical Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Korea Pharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.